`Give statins to the elderly'

Pownall, Mark
November 2002
GP: General Practitioner;11/25/2002, p4
Focuses on the prescription of general practitioners in Great Britain to use statins, cardiovascular agents for heart disease treatment of older people. Efficiency of statins to reduce heart disease related death rates in aged people; Availability of statins to elderly people in Great Britain; Role of age awareness in statin treatments.


Related Articles

  • Statin use reverses atherosclerosis progression. Davis, Stephanie // Geriatrics;Apr2007, Vol. 62 Issue 4, p8 

    The article discusses research being done on the use of statins to reverse atherosclerosis progression, with reference to a study conducted by S.J. Nicholls, E.M. Tuczu and I. Sipahi, published in a 2007 issue of "Journal of the American Medical Association." Researchers concluded that...

  • Statins. Torkos, Sherry // Alive: Canada's Natural Health & Wellness Magazine;Feb2016, Issue 400, p146 

    The article reports on the rise and fall of statins which is one of the most popular classes of drugs prescribed worldwide. Topics include the incorporation of statins into national guidelines for prevention of heart disease in those at high risk and diabetics, studies that have cast doubt on...

  • First solid evidence that lipid-lowering drugs improve CHD survival.  // Modern Medicine;Jan95, Vol. 63 Issue 1, p18 

    Reveals that long-term lipid-lowering therapy with an HMG CoA reductase inhibitor significantly reduces total mortality in patients who have coronary heart disease in Norway based on a study by Dr. Terje Pedersen. Results of previous trial of any antihyperlipidemic therapy; Kinds of `statin'...

  • Statins, fibrates valuable in heart disease treatment. Zablocki, Elaine // Managed Healthcare Executive;Jul2008, Vol. 18 Issue 7, p28 

    The article focuses on the benefits of statin medication on patients who have risk factors for heart disease in the U.S. The drug can be more effective with the combination of one of the factors such as lifestye change or with the use of other medications depending on the type of ailment. It...

  • Statins reduce adverse events in women with CVD.  // Geriatrics;Aug2002, Vol. 57 Issue 8, p41 

    Presents an abstract of the study 'Statin Therapy, Cardiovascular Events, and Total Mortality in the Heart and Estrogen/Progestin Replacement Study (HERS),' by D.M. Herrington et al., from the June 25, 2002 issue of 'Circulation.'

  • Statins bring long-term falls in non-CVD disease. Anekwe, Lilian // Pulse;9/7/2011, Vol. 71 Issue 28, p15 

    The article reports on the result of a study conducted by researchers in Great Britain, which shows that long-term intake of statins decreases the risk of non-fatal myocardial infarction and fatal coronary heart disease (CHD).

  • Cardiologists like statins-more than patients do. Mitka, Mike; Mitka, M // JAMA: Journal of the American Medical Association;12/12/2001, Vol. 286 Issue 22, p2799 

    Reports the results of a study which showed that use of statin therapy reduces the risk of major vascular events in patients at high risk for heart disease. Details of the study; Evidence that statin therapy reduced risk in patients for whom there was uncertainty about the effectiveness of...

  • Antidote. Siegel, Marc // Medical Marketing & Media;Jun2007, Vol. 42 Issue 6, p12 

    The author reflects on the effectiveness of statin drugs in patients who have never had a heart attack but are definitely at serious risk for one. The author claimed that he is taking statin drugs although he has no clinical heart disease due to some circumstances that convince him and his...

  • `-Statin' treatment of high cholesterol is cost-effective.  // Modern Medicine;Sep95, Vol. 63 Issue 9, p43 

    Presents an abstract of the report `The cost-effectiveness of HMG-CoA reductase inhibitors to prevent coronary heart disease: Estimating the benefits of increasing HDL-C,' by V.H. Hamilton et. al. published on the April 5, 1995 issue of `Journal of American Medical Association'.

  • Statins add years of life expectancy for patients with coronary artery disease.  // Modern Medicine;Nov97, Vol. 65 Issue 11, p54 

    Presents an abstract of the research `Likely Gains in Life Expectancy of Patients With Coronary Heart Disease Treated With HMG-CoA Reductase Inhibitors, as Predicted by a Decision Analysis Model,' by J. Kellett, published in the `European Journal of Surgery,' dated July 1997.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics